Table 8.
Assessment of treatment coverage during mass drug administration (MDA) 1-6
|
MDA no. |
Time of MDA |
Reported coverage for the district in%* |
Surveyed coverage in% |
|
|---|---|---|---|---|
| Community study# | School study§ | |||
| 1 |
Oct-04 |
80.0 |
82.3 |
80.0 |
| 2 |
Feb-06 |
95.0 |
79.0 |
68.2 |
| 3 |
May-07 |
87.0 |
69.9 |
61.2 |
| 4 |
Feb-09 |
96.6 |
66.8 |
32.9 |
| 5 |
Nov-09 |
98.7 |
86.4 |
43.1 |
| 6 | Dec-10 | 75.0 | 67.9 | 50.3 |
* Official NLFEP coverage for eligible individuals in Tanga District, where the three study villages and ten study schools are located.
# Assessed by interviews shortly after each MDA in the study communities (975, 1009, 883, 930, 778 and 1462 individuals aged ≥ 5 years interviewed after MDA 1-6, respectively).
§ Assessed by interviews shortly after each MDA in the 10 study schools (859, 676, 776, 836, 704 and 746 Standard 1 pupils interviewed after MDA 1-6, respectively).